High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidogenic proteins

Protein aggregation is associated with neurodegeneration and various other pathologies. How specific cellular environments modulate the aggregation of disease proteins is not well understood. Here, we investigated how the endoplasmic reticulum (ER) quality control system handles β‐sheet proteins tha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The EMBO journal 2018-02, Vol.37 (3), p.337-350
Hauptverfasser: Vincenz‐Donnelly, Lisa, Holthusen, Hauke, Körner, Roman, Hansen, Erik C, Presto, Jenny, Johansson, Jan, Sawarkar, Ritwick, Hartl, F Ulrich, Hipp, Mark S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 350
container_issue 3
container_start_page 337
container_title The EMBO journal
container_volume 37
creator Vincenz‐Donnelly, Lisa
Holthusen, Hauke
Körner, Roman
Hansen, Erik C
Presto, Jenny
Johansson, Jan
Sawarkar, Ritwick
Hartl, F Ulrich
Hipp, Mark S
description Protein aggregation is associated with neurodegeneration and various other pathologies. How specific cellular environments modulate the aggregation of disease proteins is not well understood. Here, we investigated how the endoplasmic reticulum (ER) quality control system handles β‐sheet proteins that were designed de novo to form amyloid‐like fibrils. While these proteins undergo toxic aggregation in the cytosol, we find that targeting them to the ER (ER‐β) strongly reduces their toxicity. ER‐β is retained within the ER in a soluble, polymeric state, despite reaching very high concentrations exceeding those of ER‐resident molecular chaperones. ER‐β is not removed by ER‐associated degradation (ERAD) but interferes with ERAD of other proteins. These findings demonstrate a remarkable capacity of the ER to prevent the formation of insoluble β‐aggregates and the secretion of potentially toxic protein species. Our results also suggest a generic mechanism by which proteins with exposed β‐sheet structure in the ER interfere with proteostasis. Synopsis The quality control machinery of the ER has a remarkable capacity to maintain otherwise toxic aggregation‐prone proteins in a non‐toxic liquid‐like state, which prevents them from being secreted or retranslocated to the cytoplasm. Targeting aggregation‐prone proteins to the ER strongly reduces their aggregation and toxicity. The ER quality control machinery maintains aggregation‐prone proteins in a liquid‐like state. Aggregation‐prone proteins are prevented from leaving the ER for secretion and are not retranslocated to the cytoplasm for degradation. Aggregation‐prone proteins in the ER may interfere with the degradation of other misfolded proteins by ERAD. Graphical Abstract While amyloidogenic proteins drive formation of toxic aggregates in the cytoplasm, they are tolerated in the ER by being kept in a liquid‐like state, illustrating compartment‐specific responses to protein misfolding.
doi_str_mv 10.15252/embj.201695841
format Article
fullrecord <record><control><sourceid>proquest_C6C</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_491839</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1993021753</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6171-34689355cd78a504f60ed285c0f507c874b3220998ce948abf2845684665d6b73</originalsourceid><addsrcrecordid>eNqFkcFvFCEUxonR2LV69mZIPE8LDAzgwUSbatvUeNEzYZg3s6wzwwgzbfa_l3bXzfZgPAGP3_fxHh9Cbyk5o4IJdg5DvTljhFZaKE6foRXlFSkYkeI5WhFW0YJTpU_Qq5Q2hBChJH2JTphmXBKpVshf-W6NnZ2s8_MWhxbPa8AwNmHqbRq8wxFm75Z-GfAc8BThDsYZJ3AP9TBiOzbYdl2Ezj6es4Mdtn3wTehgzPophhn8mF6jF63tE7zZr6fo55fLHxdXxe33r9cXn24LV1FJi5JXSpdCuEYqKwhvKwINU8KRVhDplOR1yRjRWjnQXNm6ZYqLSvGqEk1Vy_IUFTvfdA_TUpsp-sHGrQnWm33pV96B4ZqqUmf-447PNwM0Lo8Xbf9E9vRm9GvThTsjpC4VYdng_d4ght8LpNlswhLHPKOhWpeEUSnKTJ3vKBdDShHawwuUmMcszUOW5pBlVrw7buzA_w0vAx92wL3vYfs_P3P57fPNsTvZf1PWjR3Eo67_0dAfSf-9qw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1993021753</pqid></control><display><type>article</type><title>High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidogenic proteins</title><source>Springer Nature OA Free Journals</source><creator>Vincenz‐Donnelly, Lisa ; Holthusen, Hauke ; Körner, Roman ; Hansen, Erik C ; Presto, Jenny ; Johansson, Jan ; Sawarkar, Ritwick ; Hartl, F Ulrich ; Hipp, Mark S</creator><creatorcontrib>Vincenz‐Donnelly, Lisa ; Holthusen, Hauke ; Körner, Roman ; Hansen, Erik C ; Presto, Jenny ; Johansson, Jan ; Sawarkar, Ritwick ; Hartl, F Ulrich ; Hipp, Mark S</creatorcontrib><description>Protein aggregation is associated with neurodegeneration and various other pathologies. How specific cellular environments modulate the aggregation of disease proteins is not well understood. Here, we investigated how the endoplasmic reticulum (ER) quality control system handles β‐sheet proteins that were designed de novo to form amyloid‐like fibrils. While these proteins undergo toxic aggregation in the cytosol, we find that targeting them to the ER (ER‐β) strongly reduces their toxicity. ER‐β is retained within the ER in a soluble, polymeric state, despite reaching very high concentrations exceeding those of ER‐resident molecular chaperones. ER‐β is not removed by ER‐associated degradation (ERAD) but interferes with ERAD of other proteins. These findings demonstrate a remarkable capacity of the ER to prevent the formation of insoluble β‐aggregates and the secretion of potentially toxic protein species. Our results also suggest a generic mechanism by which proteins with exposed β‐sheet structure in the ER interfere with proteostasis. Synopsis The quality control machinery of the ER has a remarkable capacity to maintain otherwise toxic aggregation‐prone proteins in a non‐toxic liquid‐like state, which prevents them from being secreted or retranslocated to the cytoplasm. Targeting aggregation‐prone proteins to the ER strongly reduces their aggregation and toxicity. The ER quality control machinery maintains aggregation‐prone proteins in a liquid‐like state. Aggregation‐prone proteins are prevented from leaving the ER for secretion and are not retranslocated to the cytoplasm for degradation. Aggregation‐prone proteins in the ER may interfere with the degradation of other misfolded proteins by ERAD. Graphical Abstract While amyloidogenic proteins drive formation of toxic aggregates in the cytoplasm, they are tolerated in the ER by being kept in a liquid‐like state, illustrating compartment‐specific responses to protein misfolding.</description><identifier>ISSN: 0261-4189</identifier><identifier>EISSN: 1460-2075</identifier><identifier>DOI: 10.15252/embj.201695841</identifier><identifier>PMID: 29247078</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Agglomeration ; Amyloid ; Amyloidogenesis ; Amyloidogenic Proteins - metabolism ; Cell Line, Tumor ; Chaperones ; Control systems ; Cytoplasm ; Cytosol ; Degradation ; EMBO20 ; EMBO31 ; EMBO32 ; Endoplasmic reticulum ; Endoplasmic Reticulum - metabolism ; Endoplasmic Reticulum-Associated Degradation - physiology ; Fibrils ; HEK293 Cells ; HeLa Cells ; Humans ; Molecular Chaperones - metabolism ; Neurodegeneration ; protein aggregation ; Protein Aggregation, Pathological - pathology ; Protein Aggregation, Pathological - prevention &amp; control ; Protein Conformation, beta-Strand - physiology ; Protein Folding ; Protein interaction ; Proteins ; proteostasis ; Quality control ; RNA Interference ; RNA, Small Interfering - genetics ; Secretion ; Toxicity ; Unfolded Protein Response - physiology</subject><ispartof>The EMBO journal, 2018-02, Vol.37 (3), p.337-350</ispartof><rights>The Authors 2017</rights><rights>2017 The Authors</rights><rights>2017 The Authors.</rights><rights>2018 EMBO</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6171-34689355cd78a504f60ed285c0f507c874b3220998ce948abf2845684665d6b73</citedby><cites>FETCH-LOGICAL-c6171-34689355cd78a504f60ed285c0f507c874b3220998ce948abf2845684665d6b73</cites><orcidid>0000-0002-0497-3016 ; 0000-0002-7941-135X ; 0000-0001-8825-7166</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793802/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793802/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,550,723,776,780,881,1411,1427,27901,27902,41096,42165,45550,45551,46384,46808,51551,53766,53768</link.rule.ids><linktorsrc>$$Uhttps://doi.org/10.15252/embj.201695841$$EView_record_in_Springer_Nature$$FView_record_in_$$GSpringer_Nature</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29247078$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:137516363$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Vincenz‐Donnelly, Lisa</creatorcontrib><creatorcontrib>Holthusen, Hauke</creatorcontrib><creatorcontrib>Körner, Roman</creatorcontrib><creatorcontrib>Hansen, Erik C</creatorcontrib><creatorcontrib>Presto, Jenny</creatorcontrib><creatorcontrib>Johansson, Jan</creatorcontrib><creatorcontrib>Sawarkar, Ritwick</creatorcontrib><creatorcontrib>Hartl, F Ulrich</creatorcontrib><creatorcontrib>Hipp, Mark S</creatorcontrib><title>High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidogenic proteins</title><title>The EMBO journal</title><addtitle>EMBO J</addtitle><addtitle>EMBO J</addtitle><description>Protein aggregation is associated with neurodegeneration and various other pathologies. How specific cellular environments modulate the aggregation of disease proteins is not well understood. Here, we investigated how the endoplasmic reticulum (ER) quality control system handles β‐sheet proteins that were designed de novo to form amyloid‐like fibrils. While these proteins undergo toxic aggregation in the cytosol, we find that targeting them to the ER (ER‐β) strongly reduces their toxicity. ER‐β is retained within the ER in a soluble, polymeric state, despite reaching very high concentrations exceeding those of ER‐resident molecular chaperones. ER‐β is not removed by ER‐associated degradation (ERAD) but interferes with ERAD of other proteins. These findings demonstrate a remarkable capacity of the ER to prevent the formation of insoluble β‐aggregates and the secretion of potentially toxic protein species. Our results also suggest a generic mechanism by which proteins with exposed β‐sheet structure in the ER interfere with proteostasis. Synopsis The quality control machinery of the ER has a remarkable capacity to maintain otherwise toxic aggregation‐prone proteins in a non‐toxic liquid‐like state, which prevents them from being secreted or retranslocated to the cytoplasm. Targeting aggregation‐prone proteins to the ER strongly reduces their aggregation and toxicity. The ER quality control machinery maintains aggregation‐prone proteins in a liquid‐like state. Aggregation‐prone proteins are prevented from leaving the ER for secretion and are not retranslocated to the cytoplasm for degradation. Aggregation‐prone proteins in the ER may interfere with the degradation of other misfolded proteins by ERAD. Graphical Abstract While amyloidogenic proteins drive formation of toxic aggregates in the cytoplasm, they are tolerated in the ER by being kept in a liquid‐like state, illustrating compartment‐specific responses to protein misfolding.</description><subject>Agglomeration</subject><subject>Amyloid</subject><subject>Amyloidogenesis</subject><subject>Amyloidogenic Proteins - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Chaperones</subject><subject>Control systems</subject><subject>Cytoplasm</subject><subject>Cytosol</subject><subject>Degradation</subject><subject>EMBO20</subject><subject>EMBO31</subject><subject>EMBO32</subject><subject>Endoplasmic reticulum</subject><subject>Endoplasmic Reticulum - metabolism</subject><subject>Endoplasmic Reticulum-Associated Degradation - physiology</subject><subject>Fibrils</subject><subject>HEK293 Cells</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Molecular Chaperones - metabolism</subject><subject>Neurodegeneration</subject><subject>protein aggregation</subject><subject>Protein Aggregation, Pathological - pathology</subject><subject>Protein Aggregation, Pathological - prevention &amp; control</subject><subject>Protein Conformation, beta-Strand - physiology</subject><subject>Protein Folding</subject><subject>Protein interaction</subject><subject>Proteins</subject><subject>proteostasis</subject><subject>Quality control</subject><subject>RNA Interference</subject><subject>RNA, Small Interfering - genetics</subject><subject>Secretion</subject><subject>Toxicity</subject><subject>Unfolded Protein Response - physiology</subject><issn>0261-4189</issn><issn>1460-2075</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNqFkcFvFCEUxonR2LV69mZIPE8LDAzgwUSbatvUeNEzYZg3s6wzwwgzbfa_l3bXzfZgPAGP3_fxHh9Cbyk5o4IJdg5DvTljhFZaKE6foRXlFSkYkeI5WhFW0YJTpU_Qq5Q2hBChJH2JTphmXBKpVshf-W6NnZ2s8_MWhxbPa8AwNmHqbRq8wxFm75Z-GfAc8BThDsYZJ3AP9TBiOzbYdl2Ezj6es4Mdtn3wTehgzPophhn8mF6jF63tE7zZr6fo55fLHxdXxe33r9cXn24LV1FJi5JXSpdCuEYqKwhvKwINU8KRVhDplOR1yRjRWjnQXNm6ZYqLSvGqEk1Vy_IUFTvfdA_TUpsp-sHGrQnWm33pV96B4ZqqUmf-447PNwM0Lo8Xbf9E9vRm9GvThTsjpC4VYdng_d4ght8LpNlswhLHPKOhWpeEUSnKTJ3vKBdDShHawwuUmMcszUOW5pBlVrw7buzA_w0vAx92wL3vYfs_P3P57fPNsTvZf1PWjR3Eo67_0dAfSf-9qw</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Vincenz‐Donnelly, Lisa</creator><creator>Holthusen, Hauke</creator><creator>Körner, Roman</creator><creator>Hansen, Erik C</creator><creator>Presto, Jenny</creator><creator>Johansson, Jan</creator><creator>Sawarkar, Ritwick</creator><creator>Hartl, F Ulrich</creator><creator>Hipp, Mark S</creator><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0002-0497-3016</orcidid><orcidid>https://orcid.org/0000-0002-7941-135X</orcidid><orcidid>https://orcid.org/0000-0001-8825-7166</orcidid></search><sort><creationdate>20180201</creationdate><title>High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidogenic proteins</title><author>Vincenz‐Donnelly, Lisa ; Holthusen, Hauke ; Körner, Roman ; Hansen, Erik C ; Presto, Jenny ; Johansson, Jan ; Sawarkar, Ritwick ; Hartl, F Ulrich ; Hipp, Mark S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6171-34689355cd78a504f60ed285c0f507c874b3220998ce948abf2845684665d6b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Agglomeration</topic><topic>Amyloid</topic><topic>Amyloidogenesis</topic><topic>Amyloidogenic Proteins - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Chaperones</topic><topic>Control systems</topic><topic>Cytoplasm</topic><topic>Cytosol</topic><topic>Degradation</topic><topic>EMBO20</topic><topic>EMBO31</topic><topic>EMBO32</topic><topic>Endoplasmic reticulum</topic><topic>Endoplasmic Reticulum - metabolism</topic><topic>Endoplasmic Reticulum-Associated Degradation - physiology</topic><topic>Fibrils</topic><topic>HEK293 Cells</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Molecular Chaperones - metabolism</topic><topic>Neurodegeneration</topic><topic>protein aggregation</topic><topic>Protein Aggregation, Pathological - pathology</topic><topic>Protein Aggregation, Pathological - prevention &amp; control</topic><topic>Protein Conformation, beta-Strand - physiology</topic><topic>Protein Folding</topic><topic>Protein interaction</topic><topic>Proteins</topic><topic>proteostasis</topic><topic>Quality control</topic><topic>RNA Interference</topic><topic>RNA, Small Interfering - genetics</topic><topic>Secretion</topic><topic>Toxicity</topic><topic>Unfolded Protein Response - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vincenz‐Donnelly, Lisa</creatorcontrib><creatorcontrib>Holthusen, Hauke</creatorcontrib><creatorcontrib>Körner, Roman</creatorcontrib><creatorcontrib>Hansen, Erik C</creatorcontrib><creatorcontrib>Presto, Jenny</creatorcontrib><creatorcontrib>Johansson, Jan</creatorcontrib><creatorcontrib>Sawarkar, Ritwick</creatorcontrib><creatorcontrib>Hartl, F Ulrich</creatorcontrib><creatorcontrib>Hipp, Mark S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>The EMBO journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Vincenz‐Donnelly, Lisa</au><au>Holthusen, Hauke</au><au>Körner, Roman</au><au>Hansen, Erik C</au><au>Presto, Jenny</au><au>Johansson, Jan</au><au>Sawarkar, Ritwick</au><au>Hartl, F Ulrich</au><au>Hipp, Mark S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidogenic proteins</atitle><jtitle>The EMBO journal</jtitle><stitle>EMBO J</stitle><addtitle>EMBO J</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>37</volume><issue>3</issue><spage>337</spage><epage>350</epage><pages>337-350</pages><issn>0261-4189</issn><eissn>1460-2075</eissn><abstract>Protein aggregation is associated with neurodegeneration and various other pathologies. How specific cellular environments modulate the aggregation of disease proteins is not well understood. Here, we investigated how the endoplasmic reticulum (ER) quality control system handles β‐sheet proteins that were designed de novo to form amyloid‐like fibrils. While these proteins undergo toxic aggregation in the cytosol, we find that targeting them to the ER (ER‐β) strongly reduces their toxicity. ER‐β is retained within the ER in a soluble, polymeric state, despite reaching very high concentrations exceeding those of ER‐resident molecular chaperones. ER‐β is not removed by ER‐associated degradation (ERAD) but interferes with ERAD of other proteins. These findings demonstrate a remarkable capacity of the ER to prevent the formation of insoluble β‐aggregates and the secretion of potentially toxic protein species. Our results also suggest a generic mechanism by which proteins with exposed β‐sheet structure in the ER interfere with proteostasis. Synopsis The quality control machinery of the ER has a remarkable capacity to maintain otherwise toxic aggregation‐prone proteins in a non‐toxic liquid‐like state, which prevents them from being secreted or retranslocated to the cytoplasm. Targeting aggregation‐prone proteins to the ER strongly reduces their aggregation and toxicity. The ER quality control machinery maintains aggregation‐prone proteins in a liquid‐like state. Aggregation‐prone proteins are prevented from leaving the ER for secretion and are not retranslocated to the cytoplasm for degradation. Aggregation‐prone proteins in the ER may interfere with the degradation of other misfolded proteins by ERAD. Graphical Abstract While amyloidogenic proteins drive formation of toxic aggregates in the cytoplasm, they are tolerated in the ER by being kept in a liquid‐like state, illustrating compartment‐specific responses to protein misfolding.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>29247078</pmid><doi>10.15252/embj.201695841</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-0497-3016</orcidid><orcidid>https://orcid.org/0000-0002-7941-135X</orcidid><orcidid>https://orcid.org/0000-0001-8825-7166</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 0261-4189
ispartof The EMBO journal, 2018-02, Vol.37 (3), p.337-350
issn 0261-4189
1460-2075
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_491839
source Springer Nature OA Free Journals
subjects Agglomeration
Amyloid
Amyloidogenesis
Amyloidogenic Proteins - metabolism
Cell Line, Tumor
Chaperones
Control systems
Cytoplasm
Cytosol
Degradation
EMBO20
EMBO31
EMBO32
Endoplasmic reticulum
Endoplasmic Reticulum - metabolism
Endoplasmic Reticulum-Associated Degradation - physiology
Fibrils
HEK293 Cells
HeLa Cells
Humans
Molecular Chaperones - metabolism
Neurodegeneration
protein aggregation
Protein Aggregation, Pathological - pathology
Protein Aggregation, Pathological - prevention & control
Protein Conformation, beta-Strand - physiology
Protein Folding
Protein interaction
Proteins
proteostasis
Quality control
RNA Interference
RNA, Small Interfering - genetics
Secretion
Toxicity
Unfolded Protein Response - physiology
title High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidogenic proteins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T16%3A15%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_C6C&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20capacity%20of%20the%20endoplasmic%20reticulum%20to%20prevent%20secretion%20and%20aggregation%20of%20amyloidogenic%20proteins&rft.jtitle=The%20EMBO%20journal&rft.au=Vincenz%E2%80%90Donnelly,%20Lisa&rft.date=2018-02-01&rft.volume=37&rft.issue=3&rft.spage=337&rft.epage=350&rft.pages=337-350&rft.issn=0261-4189&rft.eissn=1460-2075&rft_id=info:doi/10.15252/embj.201695841&rft_dat=%3Cproquest_C6C%3E1993021753%3C/proquest_C6C%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1993021753&rft_id=info:pmid/29247078&rfr_iscdi=true